SUPERNUS PHARMACEUTICALS, INC.
SUPN—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.68
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$718.95M
Net income
$-38.55M
Net margin
-5.4%
Gross margin
—
Dividends & financials
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported revenue of $718.95M and net income of $-38.55M, or $-0.68 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
